News

FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.
Contract Pharma19h
FDA Approves argenx’s VYVGART Hytrulo Prefilled Syringe for Self-Injection
Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...
Arialief Ingredients Under Review - What the Science Says About Customer Benefits
Clinically Inspired Nerve Support Formula Arialief Gains Attention for Targeting Root Causes of Numbness, Tingling, and ...
Argenx, Halozyme win FDA nod for Vyvgart Hytrulo prefilled syringe
The U.S. Food and Drug Administration (FDA) has approved Dutch biotech argenx’s (NASDAQ:ARGX) (OTCPK:ARGNF) autoimmune disease drug Vyvgart Hytrulo, developed with Halozyme Therapeutics (NASDAQ:HALO), ...
Endpoints News19h
Ar­genx’s Vyv­gart Hytru­lo sy­ringe is ap­proved in the US; Opthea to cut 65% of staff
Argenx's Vyvgart Hytrulo gets FDA approval for self-injection syringe, Opthea cuts 65% staff after trial failures, Protagonist reports psoriasis success, Pfizer cuts jobs, Keros reviews options ...